Shepherd Kaplan Krochuk, LLC Neurocrine Biosciences Inc Transaction History

Shepherd Kaplan Krochuk, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 11, 2018	SELL	$75.88 - $92.43 $310,652 - $378,408	-4,094 Closed	0 $0
Q4 2017 Feb 13, 2018	SELL	$58.53 - $77.59 $238,509 - $316,179	-4,075 Reduced 49.88%	4,094 $318,000
Q3 2017 Nov 14, 2017	BUY	$47.97 - $61.28 $391,866 - $500,596	8,169	8,169 $501,000

625

94.2M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Shepherd Kaplan Krochuk, LLC, based on Form 13F filings with the SEC.

Stay updated on Shepherd Kaplan Krochuk, LLC with notifications on news.